Reviewed,
UniProtKB/Swiss-Prot P02462 (CO4A1_HUMAN)
Last modified
November 24, 2009.
Version 118.
History...
Clusters with 100%,
90%,
50% identity |
Documents (6) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Collagen alpha-1(IV) chain Alternative name(s): Arresten | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) [Complete proteome] | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 1669 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Type IV collagen is the major structural component of glomerular basement membranes (GBM), forming a 'chicken-wire' meshwork together with laminins, proteoglycans and entactin/nidogen. Potently inhibits endothelial cell proliferation and angiogenesis. Inhibits angiogenesis potentially via mechanisms involving cell surface proteoglycans and the alpha and beta integrins of endothelial cells. Ref.12 Ref.17 |
| Subunit structure | There are six type IV collagen isoforms, alpha 1(IV)-alpha 6(IV), each of which can form a triple helix structure with 2 other chains to generate type IV collagen network. |
| Subcellular location | Secreted › extracellular space › extracellular matrix › basement membrane. |
| Tissue specificity | |
| Domain | Alpha chains of type IV collagen have a non-collagenous domain (NC1) at their C-terminus, frequent interruptions of the G-X-Y repeats in the long central triple-helical domain (which may cause flexibility in the triple helix), and a short N-terminal triple-helical 7S domain. |
| Post-translational modification | Lysines at the third position of the tripeptide repeating unit (G-X-Y) are hydroxylated in all cases and bind carbohydrates. Prolines at the third position of the tripeptide repeating unit (G-X-Y) are hydroxylated in some or all of the chains. Type IV collagens contain numerous cysteine residues which are involved in inter- and intramolecular disulfide bonding. 12 of these, located in the NC1 domain, are conserved in all known type IV collagens. The trimeric structure of the NC1 domains is stabilized by covalent bonds between Lys and Met residues. |
| Involvement in disease | Defects in COL4A1 are a cause of brain small vessel disease with hemorrhage [MIM:607595]. Brain small vessel diseases underlie 20 to 30 percent of ischemic strokes and a larger proportion of intracerebral hemorrhages. Inheritance is autosomal dominant. Ref.21 Defects in COL4A1 are the cause of hereditary angiopathy with nephropathy, aneurysms, and muscle cramps (HANAC) [MIM:611773]. The clinical renal manifestations include hematuria and bilateral large cysts. Histologic analysis revealed complex basement membrane defects in kidney and skin. The systemic angiopathy appears to affect both small vessels and large arteries. Ref.21 Ref.22 Defects in COL4A1 are a cause of porencephaly type 1 [MIM:175780]; also known as encephaloclastic porencephaly. Porencephaly is a term used for any cavitation or cerebrospinal fluid-filled cyst in the brain. Porencephaly type 1 is usually unilateral and results from focal destructive lesions such as fetal vascular occlusion or birth trauma. Inheritance is autosomal dominant. Ref.21 Ref.19 Ref.20 |
| Sequence similarities | Belongs to the type IV collagen family. Contains 1 collagen IV NC1 (C-terminal non-collagenous) domain. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Basement membrane Extracellular matrix Secreted |
| Coding sequence diversity | Alternative splicing Polymorphism |
| Disease | Disease mutation |
| Domain | Collagen Repeat Signal |
| PTM | Disulfide bond Glycoprotein Hydroxylation |
| Technical term | 3D-structure Complete proteome Direct protein sequencing |
| Gene Ontology (GO) | |
| Molecular function | extracellular matrix structural constituent Inferred from electronic annotation. Source: InterPro platelet-derived growth factor bindingInferred from direct assay. Source: MGI |
| Complete GO annotation... | |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: P02462-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: P02462-2) The sequence of this isoform differs from the canonical sequence as follows: 498-848: Missing. | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 27 | 27 | Ref.6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Propeptide | 28 – 172 | 145 | N-terminal propeptide (7S domain) | PRO_0000005748 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Chain | 173 – 1669 | 1497 | Collagen alpha-1(IV) chain | PRO_0000005749 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 1445 – 1669 | 225 | Collagen IV NC1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Region | 173 – 1440 | 1268 | Triple-helical region | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 126 | 1 | N-linked (GlcNAc...) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 1460 ↔ 1551 | Ref.11 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 1493 ↔ 1548 | Ref.11 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 1505 ↔ 1511 | Ref.11 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 1570 ↔ 1665 | Ref.11 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 1604 ↔ 1662 | Ref.11 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 1616 ↔ 1622 | Ref.11 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cross-link | 1533 | S-Lysyl-methionine sulfilimine (Met-Lys) (interchain with K-1651) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cross-link | 1651 | S-Lysyl-methionine sulfilimine (Lys-Met) (interchain with M-1533) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 498 – 848 | 351 | Missing in isoform 2. | VSP_034644 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 7 | 1 | V → L: dbSNP rs9515185. | VAR_030027 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 304 | 1 | P → L: dbSNP rs34843786. | VAR_044158 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 498 | 1 | G → V in HANAC. Ref.22 | VAR_044159 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 519 | 1 | G → R in HANAC. Ref.22 | VAR_044160 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 528 | 1 | G → E in HANAC. Ref.22 | VAR_044161 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 555 | 1 | T → P: dbSNP rs536174. Ref.1 Ref.3 Ref.4 Ref.7 | VAR_030511 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 562 | 1 | G → E in brain small vessel disease with hemorrhage. Ref.21 | VAR_030028 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 749 | 1 | G → S in porencephaly type 1. Ref.19 | VAR_030029 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 1130 | 1 | G → D in porencephaly type 1. Ref.20 | VAR_030030 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 1236 | 1 | G → R in porencephaly type 1. Ref.19 | VAR_030031 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 1334 | 1 | Q → H: dbSNP rs3742207. Ref.3 | VAR_020013 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 1423 | 1 | G → R in porencephaly type 1. Ref.20 | VAR_030032 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 237 – 238 | 2 | SG → KE AA sequence Ref.6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 241 | 1 | G → K AA sequence Ref.6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 319 | 1 | Q → A in CAA29075. Ref.4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 719 | 1 | N → D AA sequence Ref.8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 837 | 1 | D → Y AA sequence Ref.8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 842 | 1 | K → P AA sequence Ref.8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 896 | 1 | V → W in CAA68698. Ref.7 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 904 | 1 | E → Q AA sequence Ref.8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 914 | 1 | S → K AA sequence Ref.8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 998 | 1 | S → K AA sequence Ref.8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 1010 | 1 | K → P AA sequence Ref.8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 1012 | 1 | S → K AA sequence Ref.8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 1358 | 1 | E → Q AA sequence Ref.8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 1490 | 1 | A → T in ABE73157. Ref.17 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 1507 | 1 | I → T in ABE73157. Ref.17 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 1519 | 1 | Y → C in ABE73157. Ref.17 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 1570 | 1 | C → Y in AAM97359. Ref.16 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1446 – 1451 | 6 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1453 – 1456 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1465 – 1478 | 14 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1481 – 1484 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 1490 – 1492 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1493 – 1496 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1502 – 1505 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1509 – 1514 | 6 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1519 – 1524 | 6 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 1538 – 1544 | 7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1547 – 1555 | 9 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1557 – 1561 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1563 – 1566 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1574 – 1587 | 14 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 1589 – 1591 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1593 – 1595 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 1601 – 1603 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1604 – 1607 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1613 – 1617 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1620 – 1623 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1629 – 1634 | 6 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 1638 – 1640 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1648 – 1651 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 1655 – 1658 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 1661 – 1667 | 7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Structural organization of the gene for the alpha 1 chain of human type IV collagen." Soininen R., Huotari M., Ganguly A., Prockop D.J., Tryggvason K. J. Biol. Chem. 264:13565-13571(1989) [PubMed: 2701944] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANT PRO-555. |
| [2] | "The DNA sequence and analysis of human chromosome 13." Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L., Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E., Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E., Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T. Ross M.T.Nature 428:522-528(2004) [PubMed: 15057823] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [3] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), VARIANTS PRO-555 AND HIS-1334. Tissue: Brain. |
| [4] | "Completion of the amino acid sequence of the alpha 1 chain of human basement membrane collagen (type IV) reveals 21 non-triplet interruptions located within the collagenous domain." Brazel D., Oberbaeumer I., Dieringer H., Babel W., Glanville R.W., Deutzmann R., Kuehn K. Eur. J. Biochem. 168:529-536(1987) [PubMed: 3311751] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1-943, VARIANT PRO-555. Tissue: Placenta. |
| [5] | "The structural genes for alpha 1 and alpha 2 chains of human type IV collagen are divergently encoded on opposite DNA strands and have an overlapping promoter region." Soininen R., Huotari M., Hostikka S.L., Prockop D.J., Tryggvason K. J. Biol. Chem. 263:17217-17220(1988) [PubMed: 3182844] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-28. |
| [6] | "Amino acid sequence of the N-terminal aggregation and cross-linking region (7S domain) of the alpha 1 (IV) chain of human basement membrane collagen." Glanville R.W., Qian R.Q., Siebold B., Risteli J., Kuehn K. Eur. J. Biochem. 152:213-219(1985) [PubMed: 4043082] [Abstract] Cited for: PROTEIN SEQUENCE OF 28-243. |
| [7] | "Complete primary structure of the alpha 1-chain of human basement membrane (type IV) collagen." Soininen R., Haka-Risku T., Prockop D.J., Tryggvason K. FEBS Lett. 225:188-194(1987) [PubMed: 3691802] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 46-1257, VARIANT PRO-555. Tissue: Placenta. |
| [8] | "Structure of human-basement-membrane (type IV) collagen. Complete amino-acid sequence of a 914-residue-long pepsin fragment from the alpha 1(IV) chain." Babel W., Glanville R.W. Eur. J. Biochem. 143:545-556(1984) [PubMed: 6434307] [Abstract] Cited for: PROTEIN SEQUENCE OF 534-1447. |
| [9] | "cDNA clones coding for the pro-alpha1(IV) chain of human type IV procollagen reveal an unusual homology of amino acid sequences in two halves of the carboxyl-terminal domain." Pihlajaniemi T., Tryggvason K., Myers J.C., Kurkinen M., Lebo R., Cheung M.-C., Prockop D.J., Boyd C.D. J. Biol. Chem. 260:7681-7687(1985) [PubMed: 2581969] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1256-1669. |
| [10] | "Restricted homology between human alpha 1 type IV and other procollagen chains." Brinker J.M., Gudas L.J., Loidl H.R., Wang S.-Y., Rosenbloom J., Kefalides N.A., Myers J.C. Proc. Natl. Acad. Sci. U.S.A. 82:3649-3653(1985) [PubMed: 2582422] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1259-1669. |
| [11] | "The arrangement of intra- and intermolecular disulfide bonds in the carboxyterminal, non-collagenous aggregation and cross-linking domain of basement-membrane type IV collagen." Siebold B., Deutzmann R., Kuehn K. Eur. J. Biochem. 176:617-624(1988) [PubMed: 2844531] [Abstract] Cited for: PROTEIN SEQUENCE OF 1441-1669, DISULFIDE BONDS. Tissue: Placenta. |
| [12] | "Anti-angiogenic cues from vascular basement membrane collagen." Colorado P.C., Torre A., Kamphaus G., Maeshima Y., Hopfer H., Takahashi K., Volk R., Zamborsky E.D., Herman S., Sarkar P.K., Ericksen M.B., Dhanabal M., Simons M., Post M., Kufe D.W., Weichselbaum R.R., Sukhatme V.P., Kalluri R. Cancer Res. 60:2520-2526(2000) [PubMed: 10811134] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1441-1669, FUNCTION, TISSUE SPECIFICITY. |
| [13] | "Arresten, a collagen-derived inhibitor of angiogenesis." Fu J., Bai X., Wang W., Ruan C. Submitted (MAR-2001) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1441-1669. |
| [14] | Peng X., Yin B., Yuan J., Qiang B. Submitted (JUL-2001) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1441-1669. |
| [15] | "Molecular cloning and sequencing of human arresten gene." Zheng Q.C., Song Z.F., Zheng Y.W., Li Y.Q., Shu X. Zhonghua Shi Yan Wai Ke Za Zhi 19:46-47(2002) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1441-1669. |
| [16] | "Cloning and expression of arresten in Escherichia coli and Pachia pastoris." He A.B. Submitted (AUG-2002) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1441-1669. |
| [17] | "Construction of recombinant plasmid and prokaryotic expression in E. coli and biological activity analysis of human placenta arresten gene." Zheng J.P., Tang H.Y., Chen X.J., Yu B.F., Xie J., Wu T.C. Hepatobiliary Pancreat. Dis. Int. 5:74-79(2006) [PubMed: 16481288] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1441-1669, FUNCTION, TISSUE SPECIFICITY. Tissue: Placenta. |
| [18] | "The 1.9-A crystal structure of the noncollagenous (NC1) domain of human placenta collagen IV shows stabilization via a novel type of covalent Met-Lys cross-link." Than M.E., Henrich S., Huber R., Ries A., Mann K., Kuhn K., Timpl R., Bourenkov G.P., Bartunik H.D., Bode W. Proc. Natl. Acad. Sci. U.S.A. 99:6607-6612(2002) [PubMed: 12011424] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 1441-1669, ADDITIONAL INTERCHAIN LINKS. |
| [19] | "Mutations in Col4a1 cause perinatal cerebral hemorrhage and porencephaly." Gould D.B., Phalan F.C., Breedveld G.J., van Mil S.E., Smith R.S., Schimenti J.C., Aguglia U., van der Knaap M.S., Heutink P., John S.W.M. Science 308:1167-1171(2005) [PubMed: 15905400] [Abstract] Cited for: VARIANTS PORENCEPHALY TYPE 1 SER-749 AND ARG-1236. |
| [20] | "Novel mutations in three families confirm a major role of COL4A1 in hereditary porencephaly." Breedveld G., de Coo I.F., Lequin M.H., Arts W.F.M., Heutink P., Gould D.B., John S.W.M., Oostra B., Mancini G.M.S. J. Med. Genet. 43:490-495(2006) [PubMed: 16107487] [Abstract] Cited for: VARIANTS PORENCEPHALY TYPE 1 ASP-1130 AND ARG-1423. |
| [21] | "Role of COL4A1 in small-vessel disease and hemorrhagic stroke." Gould D.B., Phalan F.C., van Mil S.E., Sundberg J.P., Vahedi K., Massin P., Bousser M.G., Heutink P., Miner J.H., Tournier-Lasserve E., John S.W.M. N. Engl. J. Med. 354:1489-1496(2006) [PubMed: 16598045] [Abstract] Cited for: VARIANT BRAIN SMALL VESSEL DISEASE WITH HEMORRHAGE GLU-562. |
| [22] | "COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps." Plaisier E., Gribouval O., Alamowitch S., Mougenot B., Prost C., Verpont M.C., Marro B., Desmettre T., Cohen S.Y., Roullet E., Dracon M., Fardeau M., Van Agtmael T., Kerjaschki D., Antignac C., Ronco P. N. Engl. J. Med. 357:2687-2695(2007) [PubMed: 18160688] [Abstract] Cited for: VARIANTS HANAC VAL-498; ARG-519 AND GLU-528. |
| [23] | "A sulfilimine bond identified in collagen IV." Vanacore R., Ham A.-J.L., Voehler M., Sanders C.R., Conrads T.P., Veenstra T.D., Sharpless K.B., Dawson P.E., Hudson B.G. Science 325:1230-1234(2009) [PubMed: 19729652] [Abstract] Cited for: INTERCHAIN SULFILIMINE BONDS. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
M26576 M26575 Genomic DNA. Translation: AAA53098.1. AL161773, AL390755 Genomic DNA. Translation: CAH71365.1. AL390755, AL161773 Genomic DNA. Translation: CAH74130.1. AL161773, AL390755 Genomic DNA. Translation: CAM14222.1. AL390755, AL161773 Genomic DNA. Translation: CAM20295.1. BC047305 mRNA. Translation: AAH47305.1. BC151220 mRNA. Translation: AAI51221.1. X05561 mRNA. Translation: CAA29075.1. Y00706 mRNA. Translation: CAA68698.1. M10940 mRNA. Translation: AAA52006.1. M11315 mRNA. Translation: AAA52042.1. AF258349 mRNA. Translation: AAF72630.1. AF363672 mRNA. Translation: AAK53382.1. AF400431 mRNA. Translation: AAK92480.1. AY285780 mRNA. Translation: AAP43112.1. AF536207 mRNA. Translation: AAM97359.1. DQ464183 mRNA. Translation: ABE73157.1. | |||||||||||||
| IPI | IPI00743696. IPI00873684. | ||||||||||||
| PIR | CGHU4B. S16876. | ||||||||||||
| RefSeq | NP_001836.2. | ||||||||||||
| UniGene | Hs.17441 | ||||||||||||
3D structure databases | |||||||||||||
| |||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| IntAct | P02462. 2 interactions. | ||||||||||||
| STRING | P02462. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | P02462. | ||||||||||||
Proteomic databases | |||||||||||||
| PRIDE | P02462. | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000375820; ENSP00000364979; ENSG00000187498; Homo sapiens. [Genome view] | ||||||||||||
| GeneID | 1282. | ||||||||||||
| KEGG | hsa:1282. | ||||||||||||
| NMPDR | fig|9606.3.peg.9076. | ||||||||||||
| UCSC | uc001vqw.2. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 1282. | ||||||||||||
| GeneCards | GC13M109599. | ||||||||||||
| HGNC | HGNC:2202. COL4A1. | ||||||||||||
| HPA | CAB001695. | ||||||||||||
| MIM | 120130. gene. 175780. phenotype. 607595. phenotype. 611773. phenotype. | ||||||||||||
| Orphanet | 73229. Familial hematuria, autosomal dominant - retinal arteriolar tortuosity - contractures. 2940. Porencephaly. | ||||||||||||
| PharmGKB | PA26717. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| HOVERGEN | P02462. | ||||||||||||
| OMA | TPGMPGK | ||||||||||||
| OrthoDB | EOG9MPM8V | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| Reactome | REACT_13552. Integrin cell surface interactions. REACT_16888. Signaling by PDGF. REACT_18266. Axon guidance. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | P02462. | ||||||||||||
| Bgee | P02462. | ||||||||||||
| CleanEx | HS_COL4A1. | ||||||||||||
| Genevestigator | P02462. | ||||||||||||
| GermOnline | ENSG00000187498. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR016187. C-type_lectin_fold. IPR008160. Collagen. IPR001442. Collagen_VI_NC. [Graphical view] | ||||||||||||
| Gene3D | G3DSA:2.170.240.10. Procollagn4_C. 1 hit. | ||||||||||||
| Pfam | PF01413. C4. 2 hits. PF01391. Collagen. 24 hits. [Graphical view] | ||||||||||||
| SMART | SM00111. C4. 2 hits. [Graphical view] | ||||||||||||
| PROSITE | PS51403. NC1_IV. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other Resources | |||||||||||||
| NextBio | 5181. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | CO4A1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P02462 Secondary accession number(s): A7E2W4 Q9NYC5 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 13 Human chromosome 13: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with


